You are here: Industry Insights > T2DM

News List

Oral Semaglutide Reduces HbA1c, Weight in Patients With T2DM drugs
August 01, 2019
Compared with placebo, oral semaglutide monotherapy is associated with superior and clinically relevant improvements in glycated hemoglobin (HbA1c) ...
T2DM Increases Gastric Cancer Risk After H. Pylori Eradication drugs
July 24, 2019
Type 2 diabetes mellitus increases the risk for gastric cancer after treatment for Helicobacter pyloriinfection, according to a study published online in Diabetes Care.
Practitioner Empathy Has Lasting Benefit After T2DM Diagnosis drugs
July 16, 2019
Practitioner Empathy Has Lasting Benefit After T2DM Diagnosis.
ADA: Combo Injectable Controls Blood Glucose Longer in T2DM drugs
June 17, 2019
Combo Injectable Controls Blood Glucose Longer in T2DM.
ADA: Dulaglutide Tied to Decline in Cardiovascular Events in T2DM drugs
June 12, 2019
Dulaglutide Tied to Decline in Cardiovascular Events in T2DM.
Fewer New T2DM Cases Seen in Adults on Plant-Based Diet drugs
June 11, 2019
Fewer New T2DM Cases Seen in Adults on Plant-Based Diet.
ADA: Vitamin D Supplementation Does Not Lower T2DM Risk drugs
June 10, 2019
Vitamin D Supplementation Does Not Lower T2DM Risk.
Lowering Cholesterol Levels May Worsen Nerve Damage in T2DM drugs
June 06, 2019
Lowering Cholesterol Levels May Worsen Nerve Damage in T2DM.
Hip Fracture Linked to Increased Risk for Death in T2DM Patients drugs
May 30, 2019
Hip Fracture Linked to Increased Risk for Death in T2DM Patients.
Incidence of End-Stage Kidney Disease Up in Australia drugs
January 02, 2019
For nonindigenous people with type 2 diabetes mellitus (T2DM) in Australia, the age-standardized incidence of end-stage kidney disease (ESKD) increased from 2002 to 2013....

Previous page 1 2 3 Next page